PROTECT PHARMACEUTICAL Corp
company.status.inactiveCIK 1493526fmd_0R26CQ8W1G20MPBSEE07M8PM97Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 1988 to Jun 30, 2018, 45 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | (0) | 0 | – | – | – |
| Cost of revenue | – | – | – | 0 | 0 | 0 | 0 | 0 | – | – |
| Gross profit | – | – | – | – | – | (0) | 0 | – | – | – |
| Research and development | – | – | 1 | 0 | – | – | – | – | – | – |
| Total operating expenses | – | – | – | – | – | – | – | – | 0 | 0 |
| Operating income | – | – | – | – | – | – | – | – | (0) | (0) |
| Interest expense | – | – | – | – | – | – | – | – | – | 0 |
| Income before taxes | – | – | – | – | – | – | – | – | (0) | (0) |
| Net income from continuing operations | – | – | (7) | (1) | (1) | (0) | (0) | (0) | (0) | – |
| Net income | (0) | (0) | (7) | (1) | (1) | (0) | 0 | (1) | (0) | (0) |